253 related articles for article (PubMed ID: 19101104)
61. Assessment of a new 18F-FDG PET/CT protocol in the staging of oral cavity carcinomas.
Cistaro A; Palandri S; Balsamo V; Migliaretti G; Pentenero M; Testa C; Cusmà S; Ceraudo F; Gandolfo S; Ficola U
J Nucl Med Technol; 2011 Mar; 39(1):7-13. PubMed ID: 21321252
[TBL] [Abstract][Full Text] [Related]
62. [18F]Fluorodeoxyglucose-PET/CT differentiation between physiological and pathological accumulations in head and neck.
Nakamura S; Okochi K; Murata Y; Shibuya H; Kurabayashi T
Nucl Med Commun; 2009 Jul; 30(7):498-503. PubMed ID: 19434008
[TBL] [Abstract][Full Text] [Related]
63. Simultaneous PET/MR imaging in a human brain PET/MR system in 50 patients--current state of image quality.
Schwenzer NF; Stegger L; Bisdas S; Schraml C; Kolb A; Boss A; Müller M; Reimold M; Ernemann U; Claussen CD; Pfannenberg C; Schmidt H
Eur J Radiol; 2012 Nov; 81(11):3472-8. PubMed ID: 22260898
[TBL] [Abstract][Full Text] [Related]
64. Fever of unknown origin: a value of (18)F-FDG-PET/CT with integrated full diagnostic isotropic CT imaging.
Ferda J; Ferdová E; Záhlava J; Matejovic M; Kreuzberg B
Eur J Radiol; 2010 Mar; 73(3):518-25. PubMed ID: 19201122
[TBL] [Abstract][Full Text] [Related]
65. 18F-fluorodeoxyglucose positron emission tomography and computed tomography in anaplastic thyroid cancer.
Poisson T; Deandreis D; Leboulleux S; Bidault F; Bonniaud G; Baillot S; Aupérin A; Al Ghuzlan A; Travagli JP; Lumbroso J; Baudin E; Schlumberger M
Eur J Nucl Med Mol Imaging; 2010 Dec; 37(12):2277-85. PubMed ID: 20694463
[TBL] [Abstract][Full Text] [Related]
66. Atypical
Childs L; Thompson A; Jones H; Hameeduddin A; Ghufoor K; Adams A
Clin Imaging; 2018; 49():136-143. PubMed ID: 29414508
[TBL] [Abstract][Full Text] [Related]
67. Positron emission tomography-computed tomography can be useful in the early detection of metastases in primary mucinous carcinoma of the skin on the head and neck.
Kitamura S; Hata H; Inamura Y; Imafuku K; Sakashita T; Hirata K; Shimizu H
Br J Dermatol; 2015 Nov; 173(5):1263-5. PubMed ID: 26147882
[TBL] [Abstract][Full Text] [Related]
68. 18F-FDG PET/CT of patients with cancer: comparison of whole-body and limited whole-body technique.
Osman MM; Chaar BT; Muzaffar R; Oliver D; Reimers HJ; Walz B; Nguyen NC
AJR Am J Roentgenol; 2010 Dec; 195(6):1397-403. PubMed ID: 21098201
[TBL] [Abstract][Full Text] [Related]
69. National survey of patient doses from whole-body FDG PET-CT examinations in France in 2011.
Etard C; Celier D; Roch P; Aubert B
Radiat Prot Dosimetry; 2012 Dec; 152(4):334-8. PubMed ID: 22586156
[TBL] [Abstract][Full Text] [Related]
70. Comparison of 18F-FDG and 11C-choline PET/CT for detecting recurrences in patients with nonsquamous cell head and neck malignancies.
Ito K; Yokoyama J; Kubota K; Morooka M
Nucl Med Commun; 2010 Nov; 31(11):931-7. PubMed ID: 20827227
[TBL] [Abstract][Full Text] [Related]
71. Validation for performing ¹¹C-methionine and ¹⁸F-FDG-PET studies on the same day.
Mitsumoto T; Kubota K; Sato T; Morooka M; Minamimoto R; Shimbo T; Muramatsu Y; Sasaki T; Ito K; Fukushi M
Nucl Med Commun; 2012 Mar; 33(3):297-304. PubMed ID: 22107999
[TBL] [Abstract][Full Text] [Related]
72. FDG PET as a procedure for detecting simultaneous tumours in head and neck cancer patients.
Nishiyama Y; Yamamoto Y; Yokoe K; Miyabe K; Ogawa T; Toyama Y; Satoh K; Ohkawa M
Nucl Med Commun; 2005 Mar; 26(3):239-44. PubMed ID: 15722904
[TBL] [Abstract][Full Text] [Related]
73. Detection of unexpected additional primary malignancies with PET/CT.
Ishimori T; Patel PV; Wahl RL
J Nucl Med; 2005 May; 46(5):752-7. PubMed ID: 15872346
[TBL] [Abstract][Full Text] [Related]
74. FDG-PET/CT in cancers of the head and neck: what is the definition of whole body scanning?
Iagaru A; Mittra ES; Gambhir SS
Mol Imaging Biol; 2011 Apr; 13(2):362-7. PubMed ID: 20495879
[TBL] [Abstract][Full Text] [Related]
75. The added benefit of a dedicated neck F-18 FDG PET-CT imaging protocol in patients with suspected recurrent differentiated thyroid carcinoma.
Davison JM; Stocker DJ; Montilla-Soler JL; Jurgens JS; Allen TW; Holley TS; Stack AL
Clin Nucl Med; 2008 Jul; 33(7):464-8. PubMed ID: 18580230
[TBL] [Abstract][Full Text] [Related]
76. F-18 FDG PET/CT following dental extraction in a patient with head and neck cancer.
Bybel B
Clin Nucl Med; 2007 Sep; 32(9):741-2. PubMed ID: 17710035
[TBL] [Abstract][Full Text] [Related]
77. Comparison of whole body positron emission tomography (PET)/PET-computed tomography and conventional anatomic imaging for detecting distant malignancies in patients with head and neck cancer: a meta-analysis.
Xu G; Li J; Zuo X; Li C
Laryngoscope; 2012 Sep; 122(9):1974-8. PubMed ID: 22753007
[TBL] [Abstract][Full Text] [Related]
78. Combined PET-CT in the head and neck: part 1. Physiologic, altered physiologic, and artifactual FDG uptake.
Blodgett TM; Fukui MB; Snyderman CH; Branstetter BF; McCook BM; Townsend DW; Meltzer CC
Radiographics; 2005; 25(4):897-912. PubMed ID: 16009814
[TBL] [Abstract][Full Text] [Related]
79. PET/CT imaging: The incremental value of assessing the glucose metabolic phenotype and the structure of cancers in a single examination.
Czernin J; Benz MR; Allen-Auerbach MS
Eur J Radiol; 2010 Mar; 73(3):470-80. PubMed ID: 20097498
[TBL] [Abstract][Full Text] [Related]
80. The impact of FDG-PET in the management of patients with salivary gland malignancy.
Otsuka H; Graham MM; Kogame M; Nishitani H
Ann Nucl Med; 2005 Dec; 19(8):691-4. PubMed ID: 16444995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
